Metrex Completes Surface Disinfectant Portfolio Efficacy Test Against SARS-CoV-2

Metrex, a global infection prevention company, offers a full portfolio of broad-spectrum surface disinfectant products that are currently on EPA’s List N1 to be used against SARS-CoV-2, the virus that causes COVID-19. Metrex has even taken a step forward and conducted efficacy testing2 via an independent third-party laboratory on our CaviWipes & CaviCide branded products against SARS-CoV-2.

The test data submitted to EPA includes disinfection label claims against SARS-CoV-2 for the following products.

In standing by our mission, we want to ensure our products can help to support healthcare professionals during this pandemic. “Even though our disinfectant products are already on EPA List N, having our CaviWipes & CaviCide family of products tested specifically against SARS-CoV-2 is an example of the high standard we always hold ourselves to, which helps to support our front-line workers with high quality products they can trust, so they can focus on the most important thing - getting the patient better. This is what our work is all about,” said Yatao Liu, Vice President and General Manager of Metrex.

“Our team takes great pride in ensuring and developing products that help to kill infectious pathogens on non-porous surfaces and prevent healthcare-associated infections.” said James Chia, Director of Research & Development of Metrex.


  1. List N: Disinfectants for Use Against SARS-CoV-2. Accessed 10.7.2020
  2. Product Performance Test Guideline, OCSPP 810.2200, Disinfectants for Use on Environmental Surfaces, Guidance for Efficacy Testing, [EPA 712-C-17-004]. Accessed 10.7.2020

Related Articles